You have 9 free searches left this month | for more free features.

bioequivalence

Showing 1 - 25 of 2,708

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bioequivalence Study Trial in Chennai (Pomalidomide 4 MG Oral Capsule)

Not yet recruiting
  • Bioequivalence Study
  • Pomalidomide 4 MG Oral Capsule
  • Chennai, Tamil Nadu, India
    Azidus Laboratories
Sep 22, 2023

Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)

Active, not recruiting
  • Bioequivalence
  • Amphotericin B liposome for injection
  • AmBisome
  • Haikou, Hainan, China
    Haikou people's Hospital
Jun 12, 2023

Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)

Not yet recruiting
  • Healthy
  • Test (T) Bilastine
  • Reference (R) Bilastine
  • (no location specified)
Oct 19, 2023

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene

Recruiting
  • Bioequivalence Study
  • Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
  • Calcium Hydroxybenzene Sulfonate Tablets(Doxium®) 250mg
  • Beijing, Beijing, China
    National Institue for Drug Clinical Trials
Mar 21, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Healthy Trial in Cairo (Bravamax 200 mg (Modafinil), Vigil 200 mg (Modafinil))

Completed
  • Healthy
  • Bravamax 200 mg (Modafinil)
  • Vigil 200 mg (Modafinil)
  • Cairo, Egypt
    Genuine Research Center GRC
May 3, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))

Completed
  • Neoplasms
  • The test olaparib tablet (T)
  • The reference olaparib tablet (R)
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
May 15, 2023

Healthy Volunteers Trial (DWJ1543, DWC202216)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Jul 21, 2023

Healthy Volunteers Trial (ABP 501, Adalimumab)

Completed
  • Healthy Volunteers
  • (no location specified)
Aug 9, 2023

Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated

Completed
  • Bioequivalence
  • Healthy Subjects
  • Efez 50 mg eplerenone film-coated tablets
  • INSPRA® 50 mg eplerenone film-coated tablets
  • Amman, Jordan
    ACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022

Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))

Completed
  • Hyperlipidemias
  • ezetimibe tablet
  • ezetimibe tablet(Ezetrol ®)
  • Qingdao, Shandong, China
    Clinical Research Center
Dec 27, 2022

Healthy Trial in Cairo (Apipe (Aripiprazole10 mg), Abilify (Aripiprazole10 mg))

Completed
  • Healthy
  • Apipe (Aripiprazole10 mg)
  • Abilify (Aripiprazole10 mg)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 27, 2023

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

Pharmacokinetics, Bioequivalence Trial in Dallas (Sumatriptan (via Intraject System))

Completed
  • Pharmacokinetics
  • Bioequivalence
  • Sumatriptan (via Intraject System)
  • Dallas, Texas
    Covance, Inc
Nov 8, 2022

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023

Healthy Volunteers Trial (DWC202307, DWJ1543, DWC202216)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Jul 21, 2023

Healthy Volunteers, Bioequivalence Study Trial in Karachi (Neurogabin (Gabapentin) 400 mg capsule, Parketin (Gabapentin) 400 mg

Completed
  • Healthy Volunteers
  • Bioequivalence Study
  • Neurogabin (Gabapentin) 400 mg capsule
  • Parketin (Gabapentin) 400 mg capsule
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Jul 1, 2022

Healthy, Pharmacokintetics Trial in Karachi (Levofloxacin 500mg)

Completed
  • Healthy
  • Pharmacokintetics
  • Levofloxacin 500mg
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Sep 5, 2022

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

COVID-19 Trial (STI-1558)

Not yet recruiting
  • COVID-19
  • (no location specified)
Sep 15, 2023

Therapeutic Equivalency Trial in Qingdao (Tested Irbesartan Tablet, Reference Irbesartan Tablet)

Completed
  • Therapeutic Equivalency
  • Tested Irbesartan Tablet
  • Reference Irbesartan Tablet
  • Qingdao, Shandong, China
    Affiliated Hospital of Qingdao University Phase I Clinical Resea
Mar 24, 2023

Healthy Trial in Qingdao (test apixaban tablets, reference apixaban tablets)

Completed
  • Healthy
  • test apixaban tablets
  • reference apixaban tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
May 1, 2023

Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)

Completed
  • Healthy Subject
  • Neomazine Tab. 100mg
  • Myungin Chlorpromazine HCl Tab. 100mg
  • Seoul, Korea, Republic of
    Whan In Pharm.
Nov 23, 2023